Look for evidence that Eisman's cautious view is wrong or overstated.

Eisman’s caution is partly right about concentration and cash burn, and overstated as a near-term systemic call. The labs he treats as fragile are scaling revenue faster than the 2025 loss figures imply, and the hyperscalers are still capacity-constrained with a large non-lab customer base. The price-war risk is real at the model layer, but so far cheaper tokens have expanded usage more than they have killed demand.

What he is actually saying

On CNBC in August and again in early October, Steve Eisman’s AI view is a concentration call, not a valuation call and not a 2008-style short. He estimates OpenAI and Anthropic account for roughly 70% of AI-related revenue at Microsoft, Amazon, Alphabet, and Oracle, and 25–35% of those firms’ cloud revenue. If either lab is impaired within about a year, he says the chain from Nvidia through the hyperscalers reverses. He calls OpenAI the weaker of the two. He has also argued the labs have no durable moat, that open-weight models are taking share, and that safety slowdown talk is a bid for regulation they can shape into a duopoly. He is still mostly long, with partial “against the box” hedges, and has said a call that the AI story implodes is premature. [1] [2] [3]

The 70% figure is his estimate. Secondary write-ups note he has not published a source for the aggregate. Microsoft’s own filing supports a narrower version: OpenAI commercial arrangements were $24.1 billion in fiscal 2026, which some estimates put near 70% of Microsoft’s AI sales, but only about 7% of company revenue and roughly a quarter of Azure. [4] [5] [6]

Lab trajectories undercut “about to break”

The prospectus numbers Eisman cites are real and ugly for 2025. Reuters reporting on Anthropic’s filing showed nearly $4.6 billion of 2025 revenue and an operating loss of more than $8 billion, with about $518 billion of multi-year compute commitments. [1] [7] That is the snapshot his caution is built on. It is already stale as a run-rate picture.

Anthropic’s subsequent reported quarters rewrote the arithmetic. Preliminary Q2 2026 revenue was about $11.5–11.6 billion, roughly 14 times the year-earlier quarter and more than double Q1’s $4.73 billion. Annualized revenue was about $65 billion at the end of July, versus about $9 billion at the end of 2025. The Financial Times reported the company told shareholders adjusted operating income would be positive for a second straight quarter, after a first adjusted operating profit in Q2, with gross margins above 80% before partner revenue share and training costs. That measure strips out stock-based compensation, so it is not free cash flow. It is still the opposite of a company one quarter from being unable to pay its bills. [8] [9] [10]

OpenAI is the cleaner place for Eisman’s “weaker company” label, and even there the revenue path has reaccelerated. Q2 recognized revenue was about $6.7 billion, up only 18% from Q1, while some reports put the operating loss, including stock-based compensation, widening from about $9.3 billion to $12.3 billion. By late September, though, sources told Reuters and Axios that annualized revenue was approaching $70 billion, up more than 70% since the start of the third quarter, with enterprise sales more than doubling since July and Q3 consumer revenue already larger than all of 2025 consumer revenue. Run rate is not audited revenue, and expenses were not disclosed. The direction still contradicts a near-term failure narrative. OpenAI raised $122 billion in March 2026 at an $852 billion post-money valuation, with later reports of talks at $1.2 trillion and above. [11] [12] [13]

What this means for the thesis: a lab can be structurally loss-making on GAAP and still be healthy enough, for the next year, to keep drawing down committed capacity. Eisman’s failure mode requires a break in growth or funding, not merely continued losses. On current reported trajectories, that break is not visible.

Hyperscaler results show demand beyond two customers

Microsoft’s July earnings call is the most direct rebuttal of the cloud-concentration version of the claim. CFO Amy Hood said full-year Microsoft Cloud revenue surpassed $214 billion, with nearly 90% from customers outside frontier-model companies. Commercial remaining performance obligation was $678 billion, up 84%. Excluding OpenAI, that backlog grew 25%, and all sequential RPO growth came from non-frontier customers. Azure grew 43% in the fourth quarter and passed $100 billion for the year. Paid Microsoft 365 Copilot seats were over 30 million. Hood also said cloud demand still exceeded available capacity. [14] [15]

That does not erase OpenAI risk inside the backlog. Earlier in fiscal 2026, OpenAI was reported at about 45% of Microsoft’s revenue backlog after a $250 billion commitment. The point is that recognized cloud revenue and incremental bookings are broader than the two-lab story, and first-party software (Copilot) is a second demand engine that does not disappear if OpenAI stumbles as a renter of GPUs. [16] [4]

Alphabet is the clearest case that AI capex can show up in both growth and margin without being an OpenAI story. Google Cloud revenue rose 82% year over year to $24.8 billion in Q2 2026. Cloud operating income more than tripled to $8.8 billion, and operating margin expanded from 20.7% to 35.6%. Backlog reached $514 billion. Management said nearly 90% of the Fortune 100 uses Gemini Enterprise, and cloud growth accelerated even after excluding the first TPU system sales into customer data centers. Quarterly free cash flow was negative $5.9 billion because capex was $44.9 billion. The cash-flow strain is real. The demand and margin evidence is also real, and it is not a bet that only two startups stay solvent. [17] [18] [19]

Amazon is in the same capacity-constrained regime. AWS revenue was $42.2 billion in Q2, up 37%, the fastest growth in 18 quarters, with backlog of $496 billion. Andy Jassy raised 2026 cash capex guidance to about $220 billion and said even that would not meet 2026 demand, and probably not 2027 demand either. Reported commentary has put AWS AI revenue at a run rate above $25 billion, at least double a year earlier, with custom chips (Graviton, Trainium, Nitro) above a $20 billion run rate. Core AWS usage is rising with AI usage, which is the flywheel a pure lab-customer story misses. [20] [21] [22]

The honest limit: Goldman Sachs has said the five largest U.S. hyperscalers need on the order of $300 billion in annual AI revenue to break even on roughly $800 billion of 2026 AI infrastructure spending, against AI cloud revenue only about $70 billion above the pre-AI trend. Capex is still running ahead of monetization in aggregate. That supports a returns debate. It does not, by itself, support “one lab fails and the U.S. is in recession overnight,” because a large share of recognized cloud revenue is already outside those two names, and several operators say they cannot build fast enough for the demand they already have. [23] [24]

Price cuts have expanded volume; revenue capture is the open question

Eisman’s price-war worry is the strongest part of the bear case, and the data so far cut both ways.

OpenRouter’s window around OpenAI’s late-July cuts to GPT-5.6 Terra and Luna is the cleanest natural experiment. Luna’s daily token volume rose 13.8 times versus its pre-discount average. Terra rose 5.6 times. Sol, which was not cut until weeks later, moved only 1.1 times and functioned as a control. OpenRouter described most of the added volume as net-new usage plus share taken from other providers, not just existing users switching SKUs. Users who adopted during the discount largely stayed, and post-discount daily volume was higher than during the promotion. [25]

The same pattern shows up in aggregate indexes. Apollo’s Torsten Slok noted in June that a token-expenditure index had roughly doubled since late 2025 even as the price of a token had fallen more than 90% since 2023. That is Jevons: unit price down, total consumption up, because new workloads (agents, coding loops, always-on inference) become viable only after the price falls. [26]

The catch, and where Eisman is not obviously wrong, is dollar capture. Goldman’s usage-weighted token price index fell 29% in August alone and more than 50% from its May peak, ending below $1 per million tokens. JPMorgan data cited alongside that report had OpenRouter token usage up about 47% month on month in August while dollar spend rose only about 7%. If price falls faster than volume rises, model-layer revenue compresses even as GPU hours rise. Cheaper intelligence can be good for Nvidia and the clouds (more tokens, more compute) and bad for the labs’ pricing power at the same time. [27] [28]

Enterprise adoption data also splits. McKinsey’s 2026 survey (1,719 respondents) found nearly nine in ten organizations using AI in at least one function, and 44% scaling it across the enterprise, up from 38%. Among firms with at least $1 billion in revenue, 54% said they were scaling, and 40% were scaling agents, up from 27%. The same survey found only 37% reporting a positive EBIT contribution, essentially unchanged from a year earlier. Breadth of use is not the same as proven profit. A price war can coexist with rising seat counts if buyers multi-home and route each workload to the cheapest adequate model. [29] [30]

Track record and the hedged stance

Outside 2008, Eisman’s public record is not a series of correctly timed systemic shorts. The career-defining call was the subprime trade. He has since said, including in a 2024 interview, that he does not expect another financial-system crisis and will not strain to predict the end of the world when he does not see it. That is a useful check on treating every Eisman warning as a Big Short sequel. [31]

The clearest miss is Tesla. He disclosed a short in July 2018 on execution and competition. By February 2020 he had covered, telling Bloomberg that when a stock becomes “unmoored from valuation” and takes on “cult-like” aspects, “you have to just walk away,” and that “there’s no glory in losing money.” Tesla had roughly doubled in 2020 alone by then; short sellers as a group were down billions. He has continued, as recently as 2025 and mid-2026, to call the shareholder base a cult and the operating record a failure. On earnings direction he has often been directionally right. As a trade, the short was wrong, and he said so by covering. [32] [33] [34]

The AI posture has the same optionality, which is why it is easy to criticize as inconsistent. In one breath the labs are nervous, moatless, and manufacturing a crisis because open-weight models are taking share. In the next, if one of them fails tomorrow the U.S. economy is in or near recession and “everybody’s in trouble.” Those claims fight each other. If open models and Google’s own stack are genuine substitutes, a lab failure reallocates spend. It does not zero out inference demand. If they are not substitutes, the “no moat, regulation is the only plan” story is weaker than he presents it.

The position matches the hedge, not the headline. He is mostly long, has trimmed rather than flipped, sleeps fine, and says an implosion call is premature. Against-the-box shorts reduce exposure without forcing a sale. That is a reasonable risk-management choice. It is not a falsifiable market call. If AI keeps working, he was long. If it breaks, he warned. The 2008 trade was the opposite: a large, explicit, money-at-risk short against a consensus that had not priced the risk.

When the thesis fails, and what to watch

The thesis fails if, over the next two to four quarters, three things hold at once.

First, both labs keep converting run rate into cash collections fast enough to service commitments. Anthropic’s adjusted profitability and OpenAI’s reacceleration are the current evidence. A stall in sequential revenue, a down round, or a public cut to contracted compute would revive the call.

Second, hyperscaler AI revenue keeps diversifying. Microsoft’s “90% of cloud revenue outside frontier-model companies,” non-OpenAI RPO growth of 25%, Copilot seat growth, Google Cloud’s 82% growth and 35.6% margin, and AWS saying demand exceeds even $220 billion of capex are the indicators that already lean against a two-customer collapse. Oracle is the exception worth separating: sell-side commentary has put OpenAI at around half of Oracle’s compute backlog, so an OpenAI problem hits Oracle harder than it hits Microsoft’s recognized P&L. [12]

Third, the price war expands total inference spend rather than only reallocating it. Token-volume spikes after price cuts support that. A sustained period in which token prices fall faster than volumes rise, and hyperscaler AI gross margins compress with them, would validate the moat critique even if the labs do not fail.

Indicators that would actually change the odds:

• Anthropic’s S-1: H1 versus H2 growth, gross margin after Amazon and Google revenue share, cash burn versus the $518 billion commitment stack, and customer concentration (the filing already flagged nearly a quarter of 2025 revenue from two clients). [35]
• OpenAI expense disclosure, not another run-rate headline. Revenue near $70 billion annualized with widening operating losses is a funding story, not a self-funding story.
• Microsoft, Amazon, and Alphabet commentary on frontier versus non-frontier mix, and whether backlog growth keeps coming from ordinary enterprises.
• Token price indexes versus token-expenditure indexes. Volume up and dollars up favors the bulls. Volume up and dollars flat favors Eisman’s price war.
• Utilization, not capex. Management already says demand exceeds supply. The bearish turn is idle capacity, guide-downs, or lengthening sales cycles, not another capex raise.
• The 10-year yield, which Eisman himself has flagged: he has said a 10-year that stays above 5% makes a correction probable, because the AI buildout is now partly a credit trade. That is a rates call sitting on top of the concentration call, and it can be right even if the labs keep growing. [36]

Bottom line: the 2025 loss figures and the customer-concentration math are a real risk to the most levered links, especially Oracle and anyone who underwrote multi-year lab commitments as if they were investment-grade demand. They are a weak basis for “everybody’s in trouble” over the next year. The labs’ 2026 revenue paths, Microsoft’s non-frontier cloud mix, Google Cloud’s margin expansion, and the post-discount token surge are the evidence that the cautious view, as a systemic near-term call, is running ahead of the operating data.

---

Recent Findings Supplement (October 2026)

Eisman's core caution centers on extreme concentration risk (roughly 70% of hyperscaler AI revenue tied to OpenAI and Anthropic), potential fragility at OpenAI, and incentives for labs to push safety narratives for regulatory moats amid eroding pricing power. Recent data from mid-2026 onward provides counter-evidence through accelerating revenue at the labs themselves, strong monetization and margins at hyperscalers, rapid enterprise scaling with emerging ROI, and clear volume elasticity from price cuts.[1][2]

OpenAI and Anthropic show explosive revenue growth and funding momentum that undercuts narratives of imminent trouble or over-dependence fragility. OpenAI's annualized revenue run rate approached $70 billion by late September 2026 (up more than 70% since the start of Q3), with enterprise sales more than doubling in that period and Q3 consumer revenue exceeding all of 2025 combined; it is in talks for at least $30 billion more at around a $1.4 trillion pre-money valuation as a bridge to a potential 2027 IPO (following the March 2026 $122 billion round at $852 billion post-money).[3][4]

Anthropic closed a $65 billion Series H in May 2026 at a $965 billion post-money valuation (surpassing OpenAI at the time), with its run rate reaching $47 billion by May and $65 billion by July/August; its 2025 full-year revenue hit nearly $4.6 billion (12x growth from ~$386 million), and a leaked September 2026 IPO prospectus highlighted gross margins swinging to roughly 40% (from deeply negative) alongside $20+ billion in cash despite large operating losses and $518 billion in multi-year infrastructure commitments.[5][6][7]

These trajectories indicate the labs are scaling revenue faster than many expected, with Anthropic appearing ahead on some metrics and both attracting massive follow-on capital despite concentration concerns. For competitors or entrants, this suggests the "two-lab dependency" may prove more resilient than feared if growth continues, but it also highlights the need to monitor actual diversification away from frontier-model reliance and paths to sustained positive free cash flow.

Hyperscaler capex is delivering accelerating cloud revenue and margins, providing validation rather than evidence of unsustainable spend. In Q2 2026, Google Cloud revenue jumped 82% year-over-year to $24.8 billion (accelerating from 63% prior quarter) with operating income more than tripling to $8.8 billion (35.6% margin); Microsoft Azure grew 43% (beating guidance and consensus), with commercial RPO at $678 billion (+84% YoY) and continued H2 acceleration expected; AWS grew 37% (fastest pace in 18 quarters).[8][9]

2026 capex guidance remains elevated (Microsoft ~$175 billion after lease accounting shifts, Amazon ~$220 billion, Alphabet $195–205 billion, Meta $130–145 billion; aggregate hundreds of billions), funded partly by record AI-related debt issuance (~$500 billion by early August), yet cloud backlogs and growth rates suggest demand is absorbing capacity.[10][11] Some analyses flag potential near-term cash-flow pressure as capex trends toward or past operating cash flow in aggregate by late 2026, but profitability and backlog conversion provide a buffer.[12]

This dynamic weakens claims of pure circular or value-destructive spending; instead, it points to AI infrastructure monetizing via higher cloud attach rates and workloads. Entrants should watch Q3/Q4 earnings for margin sustainability and whether growth rates hold as base effects grow.

Enterprise AI adoption data reveals rapid scaling, agentic deployment, and emerging ROI, moving beyond pilots toward production impact. McKinsey's 2026 survey found 44% of organizations scaling AI enterprise-wide (up from 38%), with 40% of large enterprises scaling AI agents (up from 27%); 60% expect higher AI investment.[13] Deloitte's 2026 report noted worker AI access rose 50% in 2025, with the share of companies expecting ≥40% of experiments in production set to double within six months, alongside rising reports of transformative (not just efficiency) impact.[14]

BCG's Applied AI Index 2026 indicated nearly half of companies now generate real value from AI (sharp reversal from prior minimal returns), with "future-built" leaders delivering 2.3x TSR, 2.4x revenue growth, and 2.8x EBITDA growth versus laggards; spending has risen to ~3.3% of revenue.[15] OpenAI's own enterprise signals showed agentic use (e.g., Codex) comprising 64% of tokens among customers by June, with frontier firms generating 8.3x more output tokens per user than typical ones (gap widening threefold since January).[16]

Broader surveys show 73–88% of enterprises using AI in at least one function, though full scaling remains uneven (e.g., only ~7–15% fully scaled in some reports).[17][18] These figures suggest adoption is deeper and more value-accretive than a pure hype narrative allows, particularly in large firms and specific functions like coding/agents. Implications for market participants include focusing on integration/governance tools rather than raw model access, as scaling bottlenecks shift from tech to org design.

Price cuts are driving substantial usage increases that support overall spending and revenue potential, consistent with demand elasticity rather than margin destruction. OpenAI's ~80% cut on GPT-5.6 Luna in July 2026 produced roughly a tenfold usage increase (per CFO comments), helping it gain OpenRouter market share.[19][20] Subsequent September 2026 launches (e.g., GPT-6 Sol/Luna at ~50% lower pricing than predecessors; Anthropic Opus 5.5 with ~20–40% effective savings via efficiency) coincided with further usage spikes and reports of rising token consumption offsetting per-token declines.[21][22]

Analyst notes (e.g., Citadel Securities) highlight that falling per-token costs are fueling additional usage and lifting aggregate AI spending, echoing Jevons Paradox dynamics where efficiency expands total demand.[22][23] This directly challenges concerns that competition or cuts will erode the economics sustaining hyperscaler and lab investments. For pricing strategy, it underscores the value of volume plays and efficiency gains over pure premium positioning.

Eisman's public stance mixes strong concentration warnings with a mostly-long posture and reluctance to call a full implosion, which invites criticism of inconsistency or hedging without full conviction. He has described trimming risk via partial "against the box" shorts on four unnamed AI holdings while remaining "mostly long" and calling a major downturn call "premature."[1][24] His track record is anchored in the successful 2008 subprime short (detailed in The Big Short), with other past commentary including skepticism toward for-profit education and certain financial innovations, but recent coverage emphasizes nuance on bubbles rather than repeated major misses or hits outside that era.[25]

The hedged approach—vocal risks alongside continued long exposure and statements like "I just know I sleep fine"—could be critiqued as allowing participation in upside while positioning for downside without committing to outright shorts, or as inconsistent with the severity of the concentration thesis.[1]

Eisman's thesis would likely fail (or require significant revision) under conditions such as sustained revenue diversification at hyperscalers beyond OpenAI/Anthropic, continued or accelerating token/revenue growth post-price cuts without margin collapse, durable hyperscaler cloud margins and backlog conversion proving capex returns, broad enterprise scaling delivering measurable firm-level ROI, or successful lab IPOs/fundraises demonstrating market confidence in the ecosystem. Key indicators to watch include quarterly hyperscaler cloud growth rates and operating margins (especially Google Cloud and Azure), post-cut usage and revenue elasticity metrics from labs, customer concentration disclosures or diversification trends in RPO/backlogs, enterprise agentic deployment depth and governance maturity from surveys/filings, and actual profitability trajectories or cash-flow inflection in OpenAI/Anthropic updates or prospectuses.[26]

Overall, post-April 2026 developments tilt toward resilience via growth, monetization, and elasticity, though concentration and execution risks remain material variables.